Solid Dispersion as a Strategy to Improve Drug Bioavailability
نویسندگان
چکیده
منابع مشابه
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
Solid dispersions are one of the most promising strategies to improve the oral bioavailability of poorly water soluble drugs. By reducing drug particle size to the absolute minimum, and hence improving drug wettability, bioavailability may be significantly improved. They are usually presented as amorphous products, mainly obtained by two major different methods, for example, melting and solvent...
متن کاملEnhancement of Oral Bioavailability and Solid Dispersion: A Review
Improving oral bioavailability of drugs those given as solid dosage forms remains a challenge for the formulation scientists due to solubility problems. Most of the newly invented chemical entities are poorly water soluble. As a result formulating them as oral solid dosage forms is a hurdle to the specialists. Many techniques have been exercised to improve oral bioavailability of drugs. Among s...
متن کاملSelf-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol.
Resveratrol is a nonflavonoid polyphenolic compound which has a broad range of desirable biological actions which include antioxidant, anti-inflammatory, antidiabetic, cardioprotective, and antitumor activities. However, there is concern that the bioavailability of resveratrol may limit some of its clinical utility. So, the aim of this study was to enhance the dissolution rate and oral hypoglyc...
متن کاملDrug - Drug Solid Dispersion: A Unique Approach in Solubility Enhancement
Over 40% of active pharmaceutical ingredients in development are poorly water soluble drugs which limit formulation approaches, clinical application and marketability because of their low dissolution and bioavailability. Solid dispersion has been considered one of the major advancements in overcoming these issues with several successfully marketed products. Extensive review of the literature in...
متن کاملBiosimilars as a strategy to improve sustainability
It is clearly acknowledged that competition between branded drugs and lower impact strategies (biosimilars and generics) might potentially represent a key driver to bend cancer-cost curve in the forthcoming future. In this regard, regulatory agencies (European Medicines Agency (EMA) and Food and Drug Administration) moved towards developing a specific pathway for the approval of biosimilars, al...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: KSBB Journal
سال: 2011
ISSN: 1225-7117
DOI: 10.7841/ksbbj.2011.26.4.283